Chickpea Flour Market Poised to Register 4.7% CAGR through 2026, globally - Future Market Insights
Feb 05, 2018 12:00 pm UTC| Business
Valley Cottage, NY, Feb. 05, 2018 -- As per the report by Future Market Insights (FMI), the global chickpea flour market is likely to witness moderate growth. The market is also estimated to increase to 4.7%...
Feb 05, 2018 12:00 pm UTC| Business
Conference Call and Webcast to be Held Wednesday, February 7, 2018 at 4:30pm Eastern Time NEW YORK, Feb. 05, 2018 -- Anavex Life Sciences Corp., (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage...
Fairfax to Acquire Certain Canadian Assets of Carillion
Feb 05, 2018 12:00 pm UTC| Business
TORONTO, Feb. 05, 2018 -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX:FFH) (TSX:FFH.U) and Carillion Canada Holdings Incorporated (“Carillion”) announce that they have entered into an agreement pursuant to which...
First Mining Announces Deep Exploration Drilling Results for Its Goldlund Gold Project
Feb 05, 2018 12:00 pm UTC| Business
VANCOUVER, British Columbia, Feb. 05, 2018 -- First Mining Gold Corp. (“First Mining” or the “Company”) (TSX:FF) (OTCQX:FFMGF) (Frankfurt:FMG) is pleased to announce the drilling results of the four drill holes from its...
ContraVir Pharmaceuticals Receives Positive Nasdaq Listing Determination
Feb 05, 2018 12:00 pm UTC| Business
EDISON, N.J., Feb. 05, 2018 -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the Nasdaq...
Merus Announces Participation in Four Investor Conferences in February 2018
Feb 05, 2018 12:00 pm UTC| Business
UTRECHT, The Netherlands, Feb. 05, 2018 -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the Company’s...
Bellicum Pharmaceuticals Appoints Dr. William Grossman as Chief Medical Officer
Feb 05, 2018 12:00 pm UTC| Business
HOUSTON, Feb. 05, 2018 -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the...
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma